Press Releases on January 6, 2020 - EIN Presswire - Press Release Distribution Service

Published on January 6, 2020 - 12:00 GMT

Plug Power Receives $172M Order for Hydrogen and Fuel Cell Solutions From Fortune 100 Customer

LATHAM, N.Y., Jan. 06, 2020 (GLOBE NEWSWIRE) -- Plug Power Inc. (NASDAQ: PLUG), a leading provider of hydrogen engines and fueling solutions enabling e-mobility, received an order at the close of 2019 from a Fortune 100 customer for hydrogen fuel cell …

Distribution channels: Business & Economy, Electronics Industry ...

Published on January 6, 2020 - 12:00 GMT

Calibre Announces Director Change and Establishment of Advisory Committee

VANCOUVER, British Columbia, Jan. 06, 2020 (GLOBE NEWSWIRE) -- Calibre Mining Corp. (TSX: CXB; OTCQX: CXBMF) (the “Company” or “Calibre”) announces the resignation of Dale Craig, the director nominee for B2Gold Corp. (“B2Gold”), from the Board of Directors …

Distribution channels:

Published on January 6, 2020 - 12:00 GMT

Broadwind Energy Announces Rebrand To Broadwind

CICERO, Ill., Jan. 06, 2020 (GLOBE NEWSWIRE) -- Broadwind Energy, Inc. (NASDAQ: BWEN) today announced that it has rebranded to Broadwind©. The rebranding campaign, which includes a new logo and positioning, followed by an updated website, introduces the …

Distribution channels:

Published on January 6, 2020 - 12:00 GMT

BioCryst Reports Inducement Grants Under NASDAQ Listing Rule 5635(C)(4)

RESEARCH TRIANGLE PARK, N.C., Jan. 06, 2020 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the compensation committee of BioCryst’s board of directors granted two newly-hired employees options to purchase an …

Distribution channels: Banking, Finance & Investment Industry, Healthcare & Pharmaceuticals Industry ...

Published on January 6, 2020 - 12:00 GMT

Fulcrum Therapeutics Appoints Katina Dorton to its Board of Directors

CAMBRIDGE, Mass., Jan. 06, 2020 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc. (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on improving the lives of patients with genetically defined rare diseases, today announced the appointment of …

Distribution channels: Companies, Healthcare & Pharmaceuticals Industry ...

Published on January 6, 2020 - 12:00 GMT

Parallax Health Sciences Announces Patent Enforcement Initiative

Over $500 Million in Potential Infringement Damages Present in Diagnostic and Behavioral Markets NEW YORK, NY, Jan. 06, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Parallax Health Sciences, Inc. (OTCQB: PRLX) (“Parallax” or the “Company”), an outcome- …

Distribution channels: Healthcare & Pharmaceuticals Industry, Law

Published on January 6, 2020 - 12:00 GMT

FibroGen Names Enrique Conterno as Chief Executive Officer

SAN FRANCISCO, Jan. 06, 2020 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) announced that its Board of Directors unanimously appointed Enrique Conterno as the company’s Chief Executive Officer and a member of the Board of Directors, effective today. …

Distribution channels: Companies, Technology ...

Published on January 6, 2020 - 12:00 GMT

LHC Group finalizes transactions expanding joint ventures in Texas, Arkansas, and Louisiana

LAFAYETTE, La., Jan. 06, 2020 (GLOBE NEWSWIRE) -- LHC Group, Inc. (NASDAQ: LHCG) announced today that it has finalized joint venture (JV) purchase and expansion agreements with partners in Texas, Arkansas, and Louisiana – all effective as of January 1, …

Distribution channels:

Published on January 6, 2020 - 12:00 GMT

Precision BioSciences to Present at the 38th Annual J.P. Morgan Healthcare Conference

DURHAM, N.C., Jan. 06, 2020 (GLOBE NEWSWIRE) -- Precision BioSciences, Inc. (Nasdaq: DTIL), a genome editing company dedicated to improving life through the application of its pioneering, proprietary ARCUS® platform, today announced that Matt Kane, co- …

Distribution channels:

Published on January 6, 2020 - 12:00 GMT

RYAH Announces Filing of Listing Statement with the CSE

NEW YORK, Jan. 06, 2020 (GLOBE NEWSWIRE) -- PotBotics Inc o/a RYAH. (“RYAH” or the “Company”), in conjunction with its previously announced reverse take-over transaction (“RTO”) with Prime Blockchain Inc (“Prime”), announced today that the Company has …

Distribution channels: Banking, Finance & Investment Industry, IT Industry ...

Published on January 6, 2020 - 12:00 GMT

Sorrento Announces Filing for Approval of Infliximab Biobetter Antibody by Its Partner Mabpharm in China

SAN DIEGO, Jan. 06, 2020 (GLOBE NEWSWIRE) -- Sorrento Therapeutics (Nasdaq: SRNE) announced today that its partner Mabpharm (HK:2181) filed recently a New Drug Application for the Infliximab biosimilar antibody in China. Sorrento plans to file a Biologics …

Distribution channels: Healthcare & Pharmaceuticals Industry, Technology ...

Published on January 6, 2020 - 12:00 GMT

Smile Direct Club Launches New Line of Oral Care Products Available Exclusively at Walmart

Teledentistry disruptor advances CPG collection with new products in 3800+ U.S. Walmart locations and Walmart.com End-to-end oral care system allows consumers to get a smile they’ll love at an affordable price NASHVILLE, Tenn., Jan. 06, 2020 (GLOBE …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...

Published on January 6, 2020 - 12:00 GMT

Sequential Brands Group Appoints David Conn Chief Executive Officer

NEW YORK, Jan. 06, 2020 (GLOBE NEWSWIRE) -- Sequential Brands Group, Inc. (Nasdaq:SQBG) (the "Company") today announced that brand executive David Conn has been appointed Director and Chief Executive Officer of the Company. Conn brings with him …

Distribution channels:

Published on January 6, 2020 - 12:00 GMT

Emerald Health Therapeutics Announces Second Tranche of $4.5 Million Financing

VANCOUVER, British Columbia, Jan. 06, 2020 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF), has entered into a binding term sheet with certain institutional accredited investors (the “Investors”) under which the …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...

Published on January 6, 2020 - 12:00 GMT

Hobo Cannabis Company Announces Three New Licensee Retail Locations in Ontario

Vancouver, British Columbia, Jan. 06, 2020 (GLOBE NEWSWIRE) -- Today, Hobo Cannabis Company (“Hobo”) announces three new retail locations in Ontario by way of service agreements with licensees from the province’s second lottery allocation. Launching two …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR

Published on January 6, 2020 - 12:00 GMT

Cyclacel Pharmaceuticals to Present at Biotech Showcase™ 2020 in San Francisco

BERKELEY HEIGHTS, N.J., Jan. 06, 2020 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC, Nasdaq:CYCCP) ("Cyclacel" or the "Company"), a biopharmaceutical company developing innovative medicines based on cancer cell biology …

Distribution channels:

Published on January 6, 2020 - 12:00 GMT

HOOKIPA’s Gilead Sciences Collaboration for HIV and HBV Therapeutic Vaccines Advancing Towards Clinical Entry

NEW YORK and VIENNA, Austria, Jan. 06, 2020 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (NASDAQ: HOOK, ‘HOOKIPA’), a company developing a new class of immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform, …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...

Published on January 6, 2020 - 11:55 GMT

Visteon Announces microZone High-Performance Display Technology at CES 2020

LAS VEGAS, Jan. 06, 2020 (GLOBE NEWSWIRE) -- Visteon Corporation (Nasdaq: VC), a leading automotive cockpit electronics technology company, today announced its breakthrough microZone™ display technology that offers significantly higher graphics performance …

Distribution channels: Media, Advertising & PR, Technology ...

Published on January 6, 2020 - 11:50 GMT

Osmotica Announces Proposed Public Offering of Ordinary Shares

BRIDGEWATER, N.J., Jan. 06, 2020 (GLOBE NEWSWIRE) -- Osmotica Pharmaceuticals plc (Nasdaq: OSMT) (“Osmotica” or the “Company”), a fully integrated biopharmaceutical company, announced today the commencement of a proposed public offering of 6,000,000 …

Distribution channels: Banking, Finance & Investment Industry, Healthcare & Pharmaceuticals Industry ...

Published on January 6, 2020 - 11:50 GMT

PLx Pharma Inc. Provides Regulatory Update on VAZALORE

-- PLx Aligning with the FDA on Data Requirements for VAZALORE -- FDA Approves Labeling for 325 mg -- -- Expect to Launch VAZALORE in late 2020 -- SPARTA, N.J., Jan. 06, 2020 (GLOBE NEWSWIRE) -- PLx Pharma Inc. (NASDAQ: PLXP) (“PLx” or the “Company”), a …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...